Literature DB >> 12139952

Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis.

Terry L Noah1, Sally S Ivins, Paula Murphy, Irina Kazachkova, Billie Moats-Staats, Frederick W Henderson.   

Abstract

This study measured chemokines in nasal lavage fluids (NLF) from infants with respiratory syncytial virus (RSV) bronchiolitis, defined by lung hyperinflation and wheezing. Comparison was made to RSV-positive infants without bronchiolitis and RSV-negative infants with acute respiratory illnesses. RSV-positive illnesses were associated with increased epithelial shedding, increased RANTES/protein ratios, and increased IL-8/protein ratios in NLF compared to RSV-negative illnesses. Among RSV-positive infants, bronchiolitics had greater total cell counts and percentage epithelial cells in NLF than nonbronchiolitics. Bronchiolitics also had roughly twice the NLF RANTES/IL-8 ratio than nonbronchiolitics (P =.043). Semiquantitative reverse transcriptase-polymerase chain reaction of nasal epithelium suggested similar RANTES/IL-8 ratio increases among bronchiolitics. A more mildly affected, RSV-positive outpatient population showed none of these differences. We conclude that RSV bronchiolitis is associated with a shift toward relatively more RANTES in nasal secretions of infants sick enough to require hospitalization, and mucosal epithelium may contribute to this process. Similar processes in the lower airways may enhance inflammation due to RANTES-responsive cell types and affect clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139952     DOI: 10.1006/clim.2002.5248

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

Review 1.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

2.  Respiratory syncytial virus and neutrophil activation.

Authors:  E L Bataki; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

3.  Local production of inflammatory mediators during childhood parainfluenza virus infection.

Authors:  Rana E El Feghaly; Lindsay McGann; Cynthia A Bonville; Patrick J Branigan; Manika Suryadevera; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

4.  Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation.

Authors:  Sasha J Fach; Alicia Olivier; Jack M Gallup; Theresa E Waters; Mark R Ackermann; Howard D Lehmkuhl; Randy E Sacco
Journal:  Vet Immunol Immunopathol       Date:  2010-02-13       Impact factor: 2.046

5.  Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

Authors:  Brian D Rudd; Ezra Burstein; Colin S Duckett; Xiaoxia Li; Nicholas W Lukacs
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

7.  Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Authors:  Teresa R Johnson; Marc E Rothenberg; Barney S Graham
Journal:  J Leukoc Biol       Date:  2008-06-02       Impact factor: 4.962

8.  Fosfomycin suppresses chemokine induction in airway epithelial cells infected with respiratory syncytial virus.

Authors:  Tamaki Okabayashi; Shin-ichi Yokota; Yuko Yoto; Hiroyuki Tsutsumi; Nobuhiro Fujii
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

Review 9.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.